A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
NCT07746687
This study is recruiting at 7 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to assess how well JNJ-95597528 works when compared to placebo in adult participants with moderate to severe asthma (long-term condition that affects the airways in your lungs).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Asthma
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Janssen Research & Development, LLC
- Last updated on ClinicalTrials.gov
- November 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Allianz Research Institute, Inc. · Westminster, CA
Massachusetts · 1
- Boston Specialists · Boston, MA
Minnesota · 1
- Clinical Research Institute · Minneapolis, MN
Missouri · 1
- Midwest Clinical Research LLC · St Louis, MO
New York · 1
- Equity Medical · The Bronx, NY
Oklahoma · 1
- OK Clinical Research · Edmond, OK
Texas · 1
- Allergy Asthma and Clinical Research Center Martha Tarpay MD · Oklahoma, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.